Corbin Advisors, a strategic consultancy accelerating value realization globally, today announced that Michael Newshel has been appointed as Vice President, Investor Relations (IR) Advisory and Head of Healthcare Vertical, bringing nearly two decades of sector experience as an equity research analyst at top-ranked Wall Street firms, including Evercore ISI, J.P. Morgan, and Leerink Partners.

Leveraging his experience on the sell side covering the healthcare sector and advising public companies, Mr. Newshel will oversee Corbin's Healthcare vertical, building on the firm's long-standing client relationships across the sector, including biotech, specialty and generic pharma, diagnostics, med tech, healthcare services, and IT.

"Mike is a long-tenured, Institutional Investor-ranked healthcare expert who brings nearly two decades of sector experience to our specialized talent base at Corbin,” said Rebecca Corbin, Founder and CEO of Corbin Advisors. “His extensive sell-side experience, deep equity market knowledge, and expertise across the broader healthcare ecosystem will create significant value for our healthcare clients. I look forward to working closely with Mike as we continue to grow our advisory practice based on our differentiated, data-driven approach and track record of delivering results in the form of value creation.”

Mr. Newshel adds diverse sector coverage experience to Corbin's talent mix, including across managed care and hospitals, labs, pharmacies, PBMs, healthcare IT, distributors and supply chain, and other healthcare providers. In addition, he brings deep expertise on the U.S. healthcare system, specifically policy and regulation. His most recent role was as Managing Director, Equity Research – Healthcare Services at Evercore ISI. Previously, he was VP, Healthcare Technology & Distribution at J.P. Morgan. Early in his career he was an equity research analyst at healthcare-dedicated investment bank Leerink Partners.

“I’m excited to join Corbin and apply my sell-side perspective and experience, as well as my passion for the healthcare space to help our clients elevate their equity market brand and realize their full value,” said Mr. Newshel. "Corbin continues to grow amid increasing demand for its solutions given its sterling reputation with C-suite and IR executives, differentiated client value proposition, and track record for delivering positive client outcomes, which is what initially attracted me to the firm. Having spent time learning more about what we do and engaging with colleagues and clients directly, it is apparent that Corbin has impressive talent, a distinctive culture, and a special sauce, and I'm looking forward to doing my part to advance our impact in the healthcare space and beyond.”

In addition to his professional accomplishments, Mr. Newshel is an active volunteer in his community, volunteering with several organizations, including as the treasurer and executive board member The Community Synagogue (TCS) in Westport CT and fundraising for the Lustgarten Foundation to drive research for pancreatic cancer. In his free time, Mr. Newshel enjoys coaching youth soccer and basketball.

About Corbin Advisors

Since 2007, Corbin Advisors has tracked investor sentiment on a quarterly basis. Access Inside The Buy-Side® and other research on real-time investor sentiment, IR best practices and case studies at corbinadvisors.com.

Corbin is a strategic consultancy accelerating value realization globally. We engage deeply with our clients to assess, architect, activate, and accelerate value realization, delivering research-based insights and execution excellence through a cultivated and caring team of experts with deep sector and situational experience, a best practice approach, and an outperformance mindset.

Inside The Buy-Side®, our industry-leading research publication, is covered by news affiliates globally and regularly featured on CNBC.

To learn more about us and our impact, visit CorbinAdvisors.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229858288/en/